KORZYNKO Trademark

Trademark Overview


On Wednesday, November 18, 2020, a trademark application was filed for KORZYNKO with the United States Patent and Trademark Office. The USPTO has given the KORZYNKO trademark a serial number of 79302071. The federal status of this trademark filing is REGISTERED as of Tuesday, August 3, 2021. This trademark is owned by Glaxo Group Limited. The KORZYNKO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; vaccines
korzynko

General Information


Serial Number79302071
Word MarkKORZYNKO
Filing DateWednesday, November 18, 2020
Status700 - REGISTERED
Status DateTuesday, August 3, 2021
Registration Number6436602
Registration DateTuesday, August 3, 2021
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 18, 2021

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; vaccines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, January 21, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressGB

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressGB

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGB

Trademark Events


Event DateEvent Description
Thursday, January 7, 2021SN ASSIGNED FOR SECT 66A APPL FROM IB
Tuesday, January 19, 2021LIMITATION FROM ORIGINAL APPLICATION ENTERED
Tuesday, January 26, 2021APPLICATION FILING RECEIPT MAILED
Tuesday, March 30, 2021ASSIGNED TO EXAMINER
Wednesday, April 28, 2021NOTICE OF PUBLICATION
Wednesday, April 28, 2021NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Monday, May 17, 2021NOTIFICATION PROCESSED BY IB
Thursday, January 21, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, April 12, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 28, 2021NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Tuesday, May 18, 2021PUBLISHED FOR OPPOSITION
Tuesday, August 3, 2021REGISTERED-PRINCIPAL REGISTER
Thursday, September 2, 2021GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Sunday, October 3, 2021NOTIFICATION PROCESSED BY IB
Thursday, June 5, 2025NEW REPRESENTATIVE AT IB RECEIVED
Friday, July 28, 2023CHANGE OF NAME/ADDRESS REC'D FROM IB
Wednesday, September 15, 2021FINAL DISPOSITION PROCESSED
Wednesday, September 15, 2021FINAL DISPOSITION NOTICE SENT TO IB